Georgantas Robert William III 4
4 · BIODESIX INC · Filed Apr 7, 2021
Insider Transaction Report
Form 4
BIODESIX INCBDSX
Georgantas Robert William III
DirectorSVP, Rsrch & Trans'l Science
Transactions
- Exercise/Conversion
Stock Option (Right to buy)
2021-04-05−10,219→ 19,262 totalExercise: $0.77Exp: 2030-04-14→ Common Stock (10,219 underlying) - Exercise/Conversion
Common Stock
2021-04-05$0.77/sh+10,219$7,869→ 10,774 total
Holdings
- 100(indirect: By UGMA Account)
Common Stock
Footnotes (2)
- [F1]This option vests 20% on January 1, 2021, and the remaining 80% in 48 successive, equal monthly installments measured from January 1, 2021.
- [F2]This Form 4 corrects the exercise price previously reported as $0.78 on the Form 3 filed on October 27, 2020.